Pages that link to "Q42987190"
Jump to navigation
Jump to search
The following pages link to Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide (Q42987190):
Displaying 14 items.
- A Novel Genotype of GB Virus C: Its Identification and Predominance among Injecting Drug Users in Yunnan, China (Q21560806) (← links)
- GBV-C: state of the art and future prospects (Q34247167) (← links)
- Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition (Q35077776) (← links)
- GB virus type C interactions with HIV: the role of envelope glycoproteins (Q36528539) (← links)
- GB Virus Type C Envelope Protein E2 Elicits Antibodies That React with a Cellular Antigen on HIV-1 Particles and Neutralize Diverse HIV-1 Isolates (Q36530370) (← links)
- GB virus type C E2 protein inhibits human immunodeficiency virus type 1 assembly through interference with HIV-1 gag plasma membrane targeting (Q36641639) (← links)
- Using Peptides to Study Protein–Protein Interactions (Q37855887) (← links)
- Potential utility of GB virus type C as a preventive vaccine for HIV-1. (Q37989574) (← links)
- Role of GB virus C in modulating HIV disease (Q38018981) (← links)
- Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4⁺ T-cells. (Q39216631) (← links)
- RNA interference effectively degrades mRNA and inhibits protein expression of GBV-C E2 gene in Huh7 cells (Q39790496) (← links)
- Prevalence of human pegivirus-1 and sequence variability of its E2 glycoprotein estimated from screening donors of fetal stem cell-containing material. (Q40062574) (← links)
- Phylogenetic Diversity of GB Virus C at the Antigenic Site of E2 Protein. (Q42237970) (← links)
- Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide (Q98906744) (← links)